ProfileGDS4718 / 201104_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 88% 90% 90% 92% 86% 88% 91% 94% 91% 87% 92% 86% 88% 82% 83% 90% 85% 87% 88% 88% 89% 90% 91% 88% 87% 94% 88% 91% 86% 86% 88% 89% 88% 88% 92% 86% 90% 91% 91% 90% 86% 92% 89% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6578386
GSM549102patient 115, normal, homogenized [OPG study]8.8114888
GSM549104patient 119, normal, homogenized [OPG study]9.2046390
GSM549108patient 138, normal, homogenized [OPG study]9.1570390
GSM549119patient 077, normal, homogenized [OPG study]9.5658292
GSM549133patient 032, cancer, homogenized [OPG study]8.7191286
GSM549139patient 042, cancer, homogenized [OPG study]8.9095888
GSM549099patient 107, normal, homogenized [OPG study]9.4020591
GSM549109patient 139, normal, homogenized [OPG study]10.136994
GSM549110patient 046, normal, homogenized [OPG study]9.4419291
GSM549114patient 063, normal, homogenized [OPG study]8.8844587
GSM549122patient 082, normal, homogenized [OPG study]9.5827692
GSM549134patient 033, cancer, homogenized [OPG study]8.6424186
GSM549136patient 036, cancer, homogenized [OPG study]8.9091388
GSM549140patient 044, cancer, homogenized [OPG study]8.212982
GSM549111patient 047, normal, homogenized [OPG study]8.2265183
GSM549113patient 057, normal, homogenized [OPG study]9.4219290
GSM549132patient 031, cancer, homogenized [OPG study]8.52585
GSM549137patient 038, cancer, homogenized [OPG study]8.6634387
GSM549142patient 047, cancer, homogenized [OPG study]8.4435888
GSM549100patient 110, normal, homogenized [OPG study]8.8787388
GSM549107patient 135, normal, homogenized [OPG study]9.0457689
GSM549115patient 068, normal, homogenized [OPG study]9.3698590
GSM549116patient 072, normal, homogenized [OPG study]9.3832491
GSM549120patient 078, normal, homogenized [OPG study]8.8400288
GSM549131patient 030, cancer, homogenized [OPG study]8.7838487
GSM549118patient 074, normal, homogenized [OPG study]10.104594
GSM549129patient 027, cancer, homogenized [OPG study]8.8602888
GSM549123patient 088, normal, homogenized [OPG study]9.4027791
GSM549124patient 006, cancer, homogenized [OPG study]8.5193886
GSM549126patient 015, cancer, homogenized [OPG study]8.6018286
GSM549128patient 025, cancer, homogenized [OPG study]8.8824988
GSM549103patient 117, normal, homogenized [OPG study]8.9318489
GSM549117patient 073, normal, homogenized [OPG study]9.1023788
GSM549138patient 041, cancer, homogenized [OPG study]8.9342488
GSM549141patient 045, cancer, homogenized [OPG study]9.664592
GSM549130patient 028, cancer, homogenized [OPG study]8.5125286
GSM549101patient 111, normal, homogenized [OPG study]9.2168890
GSM549105patient 128, normal, homogenized [OPG study]9.3457591
GSM549106patient 134, normal, homogenized [OPG study]9.5562191
GSM549112patient 048, normal, homogenized [OPG study]9.2322990
GSM549125patient 011, cancer, homogenized [OPG study]8.5260286
GSM549127patient 024, cancer, homogenized [OPG study]9.4786192
GSM549135patient 035, cancer, homogenized [OPG study]9.0643789